Natera Operating Cash Flow 2011-2026 | NTRA

Annual Operating Cash Flow Natera

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-432 M	-335 M	-183 M	-63.4 M	-70.6 M	-97.8 M	-74.1 M	-37.8 M	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-37.8 M	-432 M	-162 M

Quarterly Operating Cash Flow Natera

2024-Q3	2023-Q4	2023-Q3	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-137 M	-	-	-	-74.9 M	-	-109 M	-76.1 M	-35.1 M	-	-48.4 M	-35.8 M	-31.8 M	-	-57.8 M	-34.5 M	1.05 M	-	-69.7 M	-38.4 M	-24.6 M	-	-44.4 M	-20.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.05 M	-137 M	-52.3 M

Operating Cash Flow of other stocks in the Diagnostics research industry

Issuer	Operating Cash Flow	Price	% 24h	Market Cap	Country
Akumin AKU	65.4 M	-	-17.87 %	$ 25.9 M	Canada
Centogene N.V. CNTG	-21.7 M	-	-6.23 %	$ 30.6 M	Germany
Agilent Technologies A	1.48 B	$ 115.62	0.06 %	$ 35.1 B	USA
Accelerate Diagnostics AXDX	-48.7 M	-	-61.36 %	$ 2.46 M	USA
Chembio Diagnostics CEMI	-12.7 M	-	0.22 %	$ 16.8 M	USA
Co-Diagnostics CODX	-29.1 M	$ 1.65	-1.2 %	$ 2.19 M	USA
Aspira Women's Health AWH	-7.03 M	-	-6.19 %	$ 10.5 M	USA
Biocept BIOC	-13.3 M	-	-13.05 %	$ 7.29 M	USA
Castle Biosciences CSTL	64.9 M	$ 24.98	2.13 %	$ 694 M	USA
Check-Cap Ltd. CHEK	-8 M	-	-	$ 9.42 M	Israel
Enzo Biochem ENZ	-26.3 M	-	-8.98 %	$ 14.8 K	USA
CareDx, Inc CDNA	42 M	$ 21.85	2.92 %	$ 1.16 B	USA
DermTech DMTK	-77 M	-	-11.32 %	$ 2.94 M	USA
Exact Sciences Corporation EXAS	491 M	-	-	$ 19.8 B	USA
Fulgent Genetics FLGT	21.1 M	$ 15.6	-4.35 %	$ 472 M	USA
HTG Molecular Diagnostics HTGM	-18.4 M	-	-20.0 %	$ 1.06 M	USA
Global Cord Blood Corporation CO	614 M	-	-	$ 399 M	China
Genetic Technologies Limited GENE	-5.66 M	-	-	$ 7.1 B	Australia
Illumina ILMN	837 M	$ 128.52	0.5 %	$ 20.4 B	USA
Genetron Holdings Limited GTH	-524 M	-	0.12 %	$ 80.1 M	China
Charles River Laboratories International CRL	738 M	$ 171.23	0.86 %	$ 8.49 B	USA
Guardant Health GH	-185 M	$ 88.5	-0.46 %	$ 11.1 B	USA
Heska Corporation HSKA	-21.8 M	-	-	$ 1.31 B	USA
Interpace Biosciences IDXG	5.83 M	$ 1.93	-2.08 %	$ 8.54 M	USA
Lantheus Holdings LNTH	390 M	$ 84.11	-0.26 %	$ 5.68 B	USA
Medpace Holdings MEDP	713 M	$ 421.37	2.64 %	$ 12.2 B	USA
QIAGEN N.V. QGEN	654 M	-	-	$ 10.6 B	Niderland
Motus GI Holdings MOTS	-11.2 M	-	-34.28 %	$ 263 K	Israel
Biomerica BMRA	-3.84 M	$ 2.18	1.87 %	$ 5.01 M	USA
ICON Public Limited Company ICLR	1.29 B	$ 103.21	1.02 %	$ 8.51 B	Irlanda
Laboratory Corporation of America Holdings LH	1.64 B	$ 263.43	-0.12 %	$ 21.9 B	USA
Neogen Corporation NEOG	58.2 M	$ 9.45	-0.94 %	$ 2.05 B	USA
Celcuity CELC	-153 M	$ 125.68	3.84 %	$ 5.88 B	USA
NeoGenomics NEO	5.23 M	$ 8.61	3.86 %	$ 1.1 B	USA
National Research Corporation NRC	26.4 M	$ 17.11	-0.7 %	$ 383 M	USA
Myriad Genetics MYGN	1.8 M	$ 4.83	1.05 %	$ 447 M	USA
Quest Diagnostics Incorporated DGX	1.89 B	$ 196.63	0.21 %	$ 21.8 B	USA
Invitae Corporation NVTA	-493 M	-	-	$ 21.2 M	USA
OpGen OPGN	-4.87 M	-	-16.95 %	$ 1.54 M	USA
PerkinElmer PKI	583 M	-	-0.91 %	$ 14.7 B	USA
Organovo Holdings ONVO	-9.46 M	-	-2.3 %	$ 19.4 M	USA
Precipio PRPO	685 K	-	-	$ 49.3 M	USA
Personalis PSNL	-45.2 M	$ 5.96	-2.3 %	$ 353 M	USA
Senseonics Holdings SENS	-59.1 M	$ 7.27	3.12 %	$ 303 M	USA
Burning Rock Biotech Limited BNR	-478 M	$ 19.06	-7.88 %	$ 205 M	China